2022
Total Hip Arthroplasty in Patients With Classic Hemophilia: A Matched Comparison of 90-Day Outcomes and 5-Year Implant Survival
Gillinov SM, Burroughs PJ, Moore HG, Rubin LE, Frumberg DB, Grauer JN. Total Hip Arthroplasty in Patients With Classic Hemophilia: A Matched Comparison of 90-Day Outcomes and 5-Year Implant Survival. The Journal Of Arthroplasty 2022, 37: 1333-1337. PMID: 35257821, PMCID: PMC9177736, DOI: 10.1016/j.arth.2022.02.107.Peer-Reviewed Original ResearchConceptsTotal hip arthroplastyNon-hemophilia patientsMinor adverse eventsSerious adverse eventsAdverse eventsClassic hemophiliaHaemophilia patientsImplant survivalHip arthroplastyGreater oddsMultivariate analysisFive-year implant survivalPrimary total hip arthroplastyAcute kidney injuryVenous thromboembolism prophylaxisElixhauser Comorbidity IndexKaplan-Meier analysisEvidence-based guidelinesThromboembolism prophylaxisVTE prophylaxisComorbidity indexKidney injuryTHA patientsFactor replacementRetrospective study
2016
Modifiable Risk Factors in Total Joint Arthroplasty: A Pilot Study.
DeFroda SF, Rubin LE, Jenkins DR. Modifiable Risk Factors in Total Joint Arthroplasty: A Pilot Study. Rhode Island Medical Journal 2016, 99: 28-31. PMID: 27128514.Peer-Reviewed Original ResearchConceptsBody mass indexTotal joint arthroplastyRisk factorsJoint arthroplastyLevel III retrospective studiesModifiable risk factorsIndex surgeonMorbid obesityDiabetes mellitusHemoglobin A1cMass indexPoor outcomeRetrospective studyArthroplasty surgeonsRisk reduction strategiesTobacco productsPilot studyReplacement proceduresStudy periodPatientsSurgeryArthroplastySignificant proportionSurgeonsOutcomes